Hims & Hers Health Inc.

11/12/2025 | Press release | Distributed by Public on 11/12/2025 19:03

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Dudum Andrew
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [HIMS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
(Last) (First) (Middle)
2269 CHESTNUT STREET, #523
3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025
(Street)
SAN FRANCISCO, CA 94123
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 791,117(1) I Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock 262,423(2) I Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
Class A Common Stock 11/07/2025 G 262,423(3) D $ 0 0 I Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
Class A Common Stock 11/07/2025 G 262,423(3) A $ 0 262,423 I Held by Trustee of Dudum Legacy 2021 Trust
Class A Common Stock 11/10/2025 J 260,000(4) D $ 0 2,423 I Held by Trustee of Dudum Legacy 2021 Trust
Class A Common Stock 1,049,692(5) I Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock 11/10/2025 G 1,049,692(6) D $ 0 0 I Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock 11/10/2025 G 1,049,692(6) A $ 0 1,049,692 I Held by Trustee of Dudum Family 2021 Trust
Class A Common Stock 508,030 I Held by Trustee of AD 2022 GRAT
Class A Common Stock 1,194,545 I Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock 186,723 I Held by Trustee of AD 2025 GRAT dated 5-27-2025
Class A Common Stock 47,524 I Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock 2,214,769 I Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Class A Common Stock 981,235(7) I Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock 1,954,379(8) I Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock 92,523 D
Class A Common Stock 11/12/2025 G 1,954,379(9) D $ 0 0 I Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock 11/12/2025 G 1,954,379(9) A $ 0 3,004,071 I Held by Trustee of Dudum Family 2021 Trust
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class V Common Stock (10) (10) (10) Class A Common Stock 8,377,623(11) 8,377,623 I Held by Andrew Dudum 2015 Trust Dated July 2, 2015
Class V Common Stock (10) (10) (10) Class A Common Stock 0 (11) 0 I Held by Trustee of the AD 2023 GRAT dated 9-5-2023

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Dudum Andrew
2269 CHESTNUT STREET, #523
SAN FRANCISCO, CA 94123
X X Chief Executive Officer

Signatures

/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum 11/12/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This amount reflects an annuity payment-in-kind of 38,068 shares of Class A Common Stock from the AD 2022 GRAT 2 dated 9-7-2022 to the Andrew Dudum 2015 Trust dated July 2, 2015 .
(2) This amount reflects an annuity payment-in-kind of 59,234 shares of Class A Common Stock from the AD 2021 GRAT 2 dated 11-1-2021 to the Andrew Dudum 2015 Trust dated July 2, 2015 .
(3) These shares represent a gift to the Dudum Legacy 2021 Trust from the AD 2021 GRAT 2 dated 11-1-2021.
(4) This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 260,000 shares of Class A Common Stock for bona fide estate planning purposes.
(5) This amount reflects an annuity payment-in-kind of 236,935 shares of Class A Common Stock from the AD 2021 GRAT dated 11-1-2021 to the Andrew Dudum 2015 Trust dated July 2, 2015.
(6) These shares represent a gift to the Dudum Family 2021 Trust from the AD 2021 GRAT dated 11-1-2021.
(7) This amount reflects annuity payments-in-kind to the Andrew Dudum 2015 Trust dated July 2, 2015 in the following amounts of Class A Common Stock: 1) 236,935 shares from the AD 2021 GRAT dated 11-1-2021; 2) 59,234 shares from the AD 2021 GRAT 2 dated 11-1-2021; 3) 38,068 shares from the AD 2022 GRAT 2 dated 9-7-2022; and 4) 216,266 shares from the AD GRAT 2023 dated 9-5-2023. The balance also includes a transfer of 586,139 Class A Shares to the AD GRAT 2023 dated 9-5-2023.
(8) This amount reflects 1) an annuity payment-in-kind of 216,266 shares of Class A Common Stock from the AD 2023 GRAT dated 9-5-2023 to the Andrew Dudum 2015 Trust dated July 2, 2015 and 2) a transfer of 586,139 Class A Common Stock to the AD GRAT 2023 dated 9-5-2023 from the Andrew Dudum 2015 Trust dated July 2, 2015.
(9) These shares represent a gift to the Dudum Family 2021 Trust from the AD 2023 GRAT dated 9-5-2023.
(10) Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of Class A Common Stock upon certain events.
(11) This amount reflects a transfer of 586,139 shares of Class V Common Stock from the AD 2023 GRAT dated 9-1-2023 to the Andrew Dudum 2015 Trust dated July 2, 2015. The reporting person is deemed to have sole voting and disposition power over the securities held by the AD 2023 GRAT dated 9-1-2023 and the Andrew Dudum 2015 Trust dated July 2, 2015.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Hims & Hers Health Inc. published this content on November 12, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on November 13, 2025 at 01:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]